Literature DB >> 1010949

Codominant inheritance in immunogenetic (IR-gene) systems.

A Ebringer, N J Deacon, C R Young.   

Abstract

Immunogenetic (IR-gene) systems consist of animals showing different quantitative antibody responses when immunized with similar doses of a given antigen. Strains of animals giving high and low antibody titres are described as high and low responders, respectively. The degree of dominance in F1 hybrid strains, obtained from a cross between high and low responder parents, can readily be calculated using the dominance index formula, which takes the value of +1 for complete dominance, -1 for complete recessivity and the value of zero for no dominance. In reviewing 1527 F1 animals, obtained from ninety-one immunogenetic systems, the degree of diminance (d) was found to be: +0-0076 +/- 0-1053 (mean +/- s.e.), which is close to a value of zero and this is consistent with codominant inheritance. It is suggested that in immunogenetic systems, both alleles are expressed as codominant genes.

Mesh:

Substances:

Year:  1976        PMID: 1010949     DOI: 10.1111/j.1744-313x.1976.tb00602.x

Source DB:  PubMed          Journal:  J Immunogenet        ISSN: 0305-1811


  4 in total

Review 1.  Immune suppression genes.

Authors:  D B Oliveira; N A Mitchison
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

2.  Immune response inversion after hyperimmunisation. Possible mechanism in the pathogenesis of HLA-linked diseases.

Authors:  C R Young; A Ebringer; J R Archer
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

3.  Immune suppression genes control the anti-F antigen response in F1 hybrids and recombinant inbred sets of mice.

Authors:  D B Oliveira; N B Nardi
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

4.  Two distinct high immune response phenotypes are both controlled by H-2 genes mapping K or I-A.

Authors:  L S Wicker; W H Hildemann
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.